Back to search

Article

Using RNA-targeting CRISPR-Cas13 and engineered U1 systems to reduce <i>ABCA4</i> splice variants in Stargardt disease

2024-03-09

Abstract excerpt

Dysregulation of the alternative splicing process results in aberrant mRNA transcripts, leading to dysfunctional proteins or nonsense-mediated decay that cause a wide range of mis-splicing diseases. Development of therapeutic strategies to target the alternative splicing process could potentially shift the mRNA splicing from disease isoforms to a normal isoform and restore functional protein. As a proof of concept...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9bb7c07c-9977-507c-a34b-23372f67e19d
DOI
10.1101/2024.03.08.584155
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Using RNA-targeting CRISPR-Cas13 and engineered U1 systems to reduce <i>ABCA4</i> splice variants in Stargardt diseaseDOI 10.1101/2024.03.08.584155
Select a neighboring publication to make it the new centre.